Physician
Harris, Mia
Harris, Mia was paid $3.42M by Medicaid between Jan 2018 and Dec 2024, across 78 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoHARRIS, MIA
NEW ORLEANS, LA 70127
NEW ORLEANS, LA 70127
33aNPI1255516720assigned 01/03/2008
33bProvider typePediatrics Physician
28Total paid$3.42M
24GClaims201,717
24DCodes billed78
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#42 of 230
Median peer was paid$429K
This provider vs. median8.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,203 | $418K | |
| 2019 | 25,145 | $525K | |
| 2020 | 25,858 | $456K | |
| 2021 | 26,391 | $501K | |
| 2022 | 28,122 | $512K | |
| 2023 | 36,856 | $529K | |
| 2024incomplete | 37,142 | $484K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 19,134 | 16,423 | $864K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 12% | 6,854 | 6,058 | $421K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 11% | 14,069 | 12,293 | $367K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 8.7% | 5,014 | 4,352 | $299K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.9% | 4,673 | 4,277 | $272K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 6.4% | 3,361 | 2,915 | $219K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 5.4% | 15,051 | 12,781 | $185K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.5% | 7,965 | 7,103 | $119K |
| 99051 | 2.4% | 6,146 | 5,273 | $83K | |
| 99381 | 2.0% | 1,035 | 913 | $68K | |
| 92551 | 2.0% | 9,693 | 8,424 | $68K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.7% | 852 | 673 | $57K |
66 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.6% | 7,339 | $55K |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.3% | 720 | $46K |
| 99383 | <1% | 421 | $29K | |
| 90474 | <1% | 2,876 | $23K | |
| 81002 | <1% | 10,718 | $23K | |
| 83655 | <1% | 2,439 | $21K | |
| 85018 | <1% | 9,667 | $18K | |
| 99173 | <1% | 11,739 | $18K | |
| 85014 | <1% | 9,589 | $18K | |
| 87428 | <1% | 787 | $18K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 303 | $17K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 483 | $17K |
| 99382 | <1% | 167 | $12K | |
| 97802 | <1% | 6,080 | $11K | |
| 96160 | <1% | 6,964 | $8K | |
| 0071A | <1% | 213 | $8K | |
| 99384 | <1% | 102 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 607 | $6K |
| 0072A | <1% | 149 | $6K | |
| 0001A | <1% | 153 | $6K | |
| 81025 | <1% | 1,096 | $5K | |
| 90620 | <1% | 815 | $5K | |
| 0002A | <1% | 123 | $5K | |
| 81003 | <1% | 1,528 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 253 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 253 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,172 | $2K |
| 90651 | <1% | 1,926 | $2K | |
| 0111A | <1% | 35 | $1K | |
| 96380 | <1% | 94 | $1K | |
| 90671 | <1% | 1,404 | $756.84 | |
| 0054A | <1% | 17 | $703.25 | |
| A7017 | Nebulizer, durable, glass or autoclavable plastic, bottle type, not used with oxygen | <1% | 118 | $688.80 |
| 69210 | <1% | 29 | $688.56 | |
| 0051A | <1% | 18 | $581.39 | |
| 99499 | <1% | 55 | $544.00 | |
| 90715 | <1% | 464 | $444.67 | |
| 90670 | <1% | 3,388 | $433.43 | |
| 90734 | <1% | 1,594 | $411.88 | |
| 90656 | <1% | 150 | $391.85 | |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 123 | $350.35 |
| 90674 | <1% | 107 | $170.00 | |
| 90716 | <1% | 495 | $150.23 | |
| 90688 | <1% | 915 | $137.50 | |
| 90686 | <1% | 3,034 | $133.71 | |
| 90680 | <1% | 2,995 | $97.06 | |
| 90707 | <1% | 491 | $76.43 | |
| 90633 | <1% | 2,903 | $29.83 | |
| 36416 | <1% | 46 | $17.71 | |
| 90700 | <1% | 1,094 | $12.50 | |
| 90648 | <1% | 2,466 | $10.55 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 18 | $8.40 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 282 | $0.45 |
| 90380 | <1% | 52 | $0.03 | |
| 90381 | <1% | 39 | $0.01 | |
| 91307 | <1% | 457 | $0.01 | |
| 90723 | 0% | 1,372 | $0.00 | |
| 90698 | 0% | 624 | $0.00 | |
| 90697 | 0% | 856 | $0.00 | |
| 90696 | 0% | 955 | $0.00 | |
| 91305 | 0% | 97 | $0.00 | |
| 90744 | 0% | 55 | $0.00 | |
| 90710 | 0% | 1,843 | $0.00 | |
| 91300 | 0% | 327 | $0.00 | |
| 91311 | 0% | 70 | $0.00 | |
| 90685 | 0% | 106 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.